Drop, tablet and powder type N-acetylneuraminic acid anti-virus composition

A technology of acetylneuraminic acid and composition, which is applied in the direction of antiviral agents, drug combinations, active ingredients of hydroxyl compounds, etc., and can solve problems such as short residence time, inability to satisfy different user groups, and single dosage form

Inactive Publication Date: 2018-08-24
浙江索契壹营养科技有限公司
View PDF6 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] However, the existing N-acetylneuraminic acid antiviral composition of anti-virus and immunity-enhancing powder type rarely utilizes N-acetylneuraminic acid. The formula formed by other ingredients lacks scientific and reasonable basis, does not give full play to the efficacy of each ingredient, and

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Drop, tablet and powder type N-acetylneuraminic acid anti-virus composition
  • Drop, tablet and powder type N-acetylneuraminic acid anti-virus composition
  • Drop, tablet and powder type N-acetylneuraminic acid anti-virus composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] A drop-type N-acetylneuraminic acid antiviral composition described in this embodiment is characterized in that it includes the following components in weight percentage: 0.6% of lactoferrin, 12% of N-acetylneuraminic acid, immune 3% globulin, 10% glycerin, 13.81% fructooligosaccharide and 40% elderberry juice concentrate, further including 2.5% vitamin C, 0.03% niacin, 5% yam, 0.5‰ potassium sorbate and 5% tangerine peel, It further includes 5% of honeysuckle, 5% of licorice, 0.01% of taurine and 3% of zinc-containing components including zinc gluconate.

Embodiment 2

[0041] A drop-type N-acetylneuraminic acid antiviral composition described in this embodiment is characterized in that it comprises the following components in weight percentage: lactoferrin 8%, N-acetylneuraminic acid 5%, immune Globulin 35%, glycerin 5%, fructooligosaccharide 10.1% and elderberry juice concentrate 10.1%, further including vitamin C 2.5%, niacin 0.18%, yam 5%, potassium sorbate 1‰ and tangerine peel 5%, It further includes 5% of honeysuckle, 5% of licorice, 0.05% of taurine and 8.069% of zinc-containing components including zinc gluconate.

Embodiment 3

[0043] A tablet-type N-acetylneuraminic acid antiviral composition described in this example includes the following components by weight percentage: lactoferrin 0.2%, N-acetylneuraminic acid 1.5%, immunoglobulin 1 % and elderberry powder 5%, further including vitamin C45%, niacin 1.8%, further including honeysuckle extract 5%, licorice extract 5%, further including taurine 0.5%, zinc gluconate 0.5%, further including Xylitol 34.5%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a drop, tablet and powder type N-acetylneuraminic acid anti-virus composition which comprises a drop agent, a tablet agent or a powder agent, wherein the drop agent comprises 0.6-12% of lactoferrin, 5-12% of N-acetylneuraminic acid, 3-6% of immune globulin, 5-10% of glycerinum, 10.1-40% of fructo-oligosaccharide and 10.1-40% of concentrated elderberry juice; the tablet agent comprises 0.2-6% of lactoferrin, 1.5-6% of N-acetylneuraminic acid, 1-45% of immune globulin and 5-15% of elderberry fruit powder; the powder agent comprises 2-20% of immune globulin, 0.1-10% of lactoferrin, 0.5-6% of N-acetylneuraminic acid, 0.01-0.5% of lactobacillus fermenti CECT5716, 0.05-0.25% of lactalbumin, 0.1-0.25% of yolk globulin and 0.02-0.1% of a food nutritive fortifier; the lactoferrin is derived from whey protein or lactoferrin; the immune globulin is derived from bovine colostrum powder or whey protein. The composition is long in respiratory tract retention time and virus combination time, and is remarkable in anti-virus effect.

Description

technical field [0001] The invention belongs to the field of medicine and health products, and in particular relates to an N-acetylneuraminic acid antiviral composition in the form of drops, tablets and powders. Background technique [0002] N-acetylneuraminic acid N-acetylneuraminic acid is the most widely distributed sialic acid (N-acylneuraminic acid) in nature, mainly composed of glycoproteins, glycolipids or bacterial capsular substances in animal cell membranes or secretions sugar. Sialic acid is a kind of neuraminic acid whose parent structure is composed of 9 carbon atoms. It is widely found in various biological tissues and is a component of complex carbohydrates on the cell surface. Sialic acid found in most mammalian tissues is mainly It is N-acetylneuraminic acid, so N-acetylneuraminic acid is usually called sialic acid. [0003] The most important nutrient in bird's nest is sialic acid. Almost all bird's nest quality standards use the content of sialic acid as...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K38/40A61K39/395A61K36/35A61K31/351A61K45/06A61K9/20A61K9/08A61K9/14A61P31/04A61P31/12A61P11/00A61K31/375A61K31/455A61K36/8945A61K36/752A61K36/355A61K36/484A61K31/185A61K33/30A61K31/315
CPCA61K9/2018A61K31/047A61K31/185A61K31/375A61K31/455A61K31/7012A61K31/7016A61K31/702A61K31/716A61K31/733A61K33/30A61K35/745A61K35/747A61K36/35A61K36/355A61K36/484A61K36/752A61K36/8945A61K38/40A61K39/395A61P31/12A61P37/04A61K2300/00
Inventor 李文霞戴晶晶柏金霞郭靖
Owner 浙江索契壹营养科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap